Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) (“Marapharm” or the “Company”) announced on June 1, 2018, that cloning had begun in preparation for the transition to the permanent facilities.
Kurt Keating, Director of Operations, reports that several hundred clones have taken root over the past eight weeks in our transitional buildings and are exhibiting vigorous growth. “Our Cultivators are in the process of a secondary ‘cutting’ of clones to commence a perpetual harvest schedule. We remain on track and do not anticipate delays to our production schedule.”
Subsequent to the Company’s June 14, 2018 news release, the City of North Las Vegasdetermined the following minor adjustments are required prior to the final granting of the Certificates of Occupancy:
Outdoor lighting provided by street light standards within the property boundaries are complete and operational. However, two off-site street light standards on the roadway leading to the Marapharm property remain unpowered and the Company is working on either getting this requirement waived by the City or providing a temporary power source to the lights.
The (2) 2,000-gallon propane tanks were originally approved for their size and installation method, however, the City has amended their requirements to include an engineered bolt system to anchor the tanks to the slab. The slab is already constructed and the propane tanks in place according to the original engineered specifications. The propane tanks can be viewed by the drone footage provided on the Marapharm website under the Las Vegas Project, however, given the City’s recent requirements the new bolt system has been fabricated and waiting for installation upon the City approval of the new drawings and permit.
Adjustments were made to the fire protection system and the inspection is complete. We have received verbal approval from the City for the design of the suppression flow and are waiting on our written permit, which is imminent.
Additional stop signs and parking signs were required and installation of these are now complete.
ABOUT MARAPHARM VENTURES INC.
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
Twitter: twitter.com/marapharm Web
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQX® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQX® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate.
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers